Biothera - Product Pipeline Review - Q4 2010

Global Markets Direct, December 2010, Pages: 36

Biothera – Product Pipeline Review – Q4 2010

Summary

Global Market Direct’s pharmaceuticals report, “Biothera - Product Pipeline Review - Q4 2010” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Biothera - Brief company overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Biothera human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Biothera with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Biothera’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Biothera - Brief company overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Biothera human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Biothera with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Biothera’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

List of Tables
List of Figures
Biothera Snapshot
Biothera Overview
Key Information
Key Facts
Biothera – Research and Development Overview
Key Therapeutic Areas
Biothera – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Combination Treatment Modalities
Biothera – Pipeline Products Glance
Biothera Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Biothera – Drug Profiles
Imprime PGG + Avastin
Product Description
Mechanism of Action
R&D Progress
Imprime PGG + Bevacizumab + Paclitaxel + Carboplatin
Product Description
Mechanism of Action
R&D Progress
Imprime PGG + Cetuximab + Paclitaxel + Carboplatin
Product Description
Mechanism of Action
R&D Progress
Imprime PGG + Erbitux
Product Description
Mechanism of Action
R&D Progress
Imprime PGG + Erbitux + Camptosar
Product Description
Mechanism of Action
R&D Progress
Biothera – Pipeline Analysis
Biothera – Pipeline Products by Therapeutic Class
Biothera Pipeline Products By Target
Biothera – Pipeline Products by Route of Administration
Biothera – Pipeline Products by Molecule Type
Biothera – Recent Pipeline Updates
Biothera - Dormant Projects
Biothera – Locations And Subsidiaries
Head Office
Recent Developments
Oct 12, 2010: Biothera Reports Combination Of Imprime PGG And Erbitux Doubles Overall Response Rate In Colorectal Cancer Clinical Trial
Jul 06, 2010: Biothera Reports Combination Of Imprime PGG And Erbitux Doubles Therapeutic Response In Colorectal Cancer Patients In Phase Ib/IIa Trial
Jun 10, 2009: Biothera Launches Clinical Trial In KRAS-Mutated Colorectal Cancer Patients
Jun 10, 2009: Biothera Launches Clinical Trial In KRAS-Mutated Colorectal Cancer Patients
May 29, 2009: Biothera Releases Colorectal Cancer Study Results At ASCO
Jan 29, 2009: Biothera Expands Metastatic Colorectal Cancer Trial
Jan 29, 2009: Biothera Expands Metastatic Colorectal Cancer Trial
Feb 28, 2008: Imprime PGG Synergistic With Avastin Against Cancer
Jun 04, 2007: Imprime PGG Enhanced Effectiveness Of Avastin In Cancer Study
Sep 19, 2006: U.S. Government Selects Biothera Compounds For National Radiation Countermeasure Evaluation
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

Customers who bought this item also bought

• Global Aerospace Composites Market 2012-2016
• Charter Schools - Global Outlook
• eLEARNING - Global Strategic Business Report
• Biodefense Industry - Market to Benefit from Federal Funding such as the BIO EDEP Fund to Support Security Plans
• Sports and Fitness Nutrition - Global Strategic Business Report
• Aerospace and Defense Industry - Global Strategic Business Report
• Education Services - Global Strategic Business Report
• Commercial And Military Flight Simulation - Global Strategic Business Report
• North America – Smart Weapons Markets and Technologies Outlook – 2013-2020
• Generic Defense Strategies: Lifecycle Management Strategies to Maximize Revenue in the Face of Growing Generic Competition